Exercise
2065 source-matched work links since 2022 · 726 since 2025 · 2035 citations across the representative sample
- Microglia states and nomenclature: A field at its crossroads · 2022 · 2035 OpenAlex citations · open access
Global University Research Index
The University of Tokyo
The University of Tokyo longevity research profile: 6524 source-matched work links across 10 tracked topics, with transparent methodology and representative sources.
76.1Transparent research index score
6524Five-year longevity work links
10Longevity topics represented
33%Share indexed since 2025
100%Open-access representative sample
Tokyo, Tokyo, Japan. This profile is generated from OpenAlex work affiliations resolved against ROR institution identities.
Topic profile
Compare universitiesWhere the indexed activity appears
Stem cells
1585 source-matched work links since 2022 · 511 since 2025 · 5011 citations across the representative sample
- Microglia states and nomenclature: A field at its crossroads · 2022 · 2035 OpenAlex citations · open access
- Cancer chemotherapy and beyond: Current status, drug candidates, associated risks and progress in targeted therapeutics · 2022 · 1789 OpenAlex citations · open access
- Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity · 2022 · 1187 OpenAlex citations · open access
Sleep
1182 source-matched work links since 2022 · 441 since 2025 · 2035 citations across the representative sample
- Microglia states and nomenclature: A field at its crossroads · 2022 · 2035 OpenAlex citations · open access
Gene therapy
861 source-matched work links since 2022 · 273 since 2025 · 0 citations across the representative sample
No representative work was retained in the current sample.
Senolytics
230 source-matched work links since 2022 · 87 since 2025 · 1789 citations across the representative sample
- Cancer chemotherapy and beyond: Current status, drug candidates, associated risks and progress in targeted therapeutics · 2022 · 1789 OpenAlex citations · open access
Rapamycin
229 source-matched work links since 2022 · 0 since 2025 · 1789 citations across the representative sample
- Cancer chemotherapy and beyond: Current status, drug candidates, associated risks and progress in targeted therapeutics · 2022 · 1789 OpenAlex citations · open access
GLP-1 therapies
150 source-matched work links since 2022 · 67 since 2025 · 1327 citations across the representative sample
- Triglyceride Lowering with Pemafibrate to Reduce Cardiovascular Risk · 2022 · 742 OpenAlex citations · open access
- Genetic drivers of heterogeneity in type 2 diabetes pathophysiology · 2024 · 585 OpenAlex citations · open access
Caloric restriction
111 source-matched work links since 2022 · 32 since 2025 · 0 citations across the representative sample
No representative work was retained in the current sample.
Partial reprogramming
57 source-matched work links since 2022 · 24 since 2025 · 417 citations across the representative sample
- Senescence atlas reveals an aged-like inflamed niche that blunts muscle regeneration · 2022 · 417 OpenAlex citations · open access
Plasma exchange
54 source-matched work links since 2022 · 20 since 2025 · 0 citations across the representative sample
No representative work was retained in the current sample.